Daklinza
Drug timelines are a Plus or Pro feature.
31 regulatory and trial events tracked for Daklinza, covering 2014-06-09 to 2019-08-30. Get the full timeline:
Most recent: EMA Expired: Daklinza (daclatasvir dihydrochloride) — Bristol-Myers Squibb Pharma EEIG